Feasibility and Effectiveness of Sentinel Lymph Node Biopsy in Inflammatory Breast Cancer

Part of paid clinical trials in Cleveland, Ohio.

Sponsor: Case Comprehensive Cancer Center
Study ID: NCT07876986
Status: Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Breast Cancer

Eligibility Criteria

Sex: FEMALE
Age: 18 Years - N/A
Healthy Volunteers: Not accepted

Interventions

Sentinel node biopsy with blue dye and radioisotope — DIAGNOSTIC_TEST
Participants will be injected with blue dye and radioisotope tracer into the breast of tumor that drains into the first axillary lymph nodes during their planned surgical procedure so that the sentinel lymph nodes can be sampled.

Study Details

This study is for participants with inflammatory breast cancer (IBC). The purpose of this study is to find out whether it is possible to take a sample of underarm lymph nodes for participants with IBC. The participants will undergo sentinel lymph node biopsy (SLNB) in addition to full axillary lymph node dissection (ALND) during the planned breast cancer surgery. Participants enrolled in the study will first be injected with tracer, then undergo SLNB, and then undergo full ALND.